U.S. Gender-Affirming Surgeries Nearly Tripled in 3 Years
WEDNESDAY, Aug. 23, 2023 (HealthDay News) — The number of Americans undergoing gender-affirming surgery is on the rise, new research reveals, almost tripling between 2016 and 2019 alone.During that period, more than 48,000 patients — about half of t…
Learn MoreAHA News: Promotores Create a Bridge Between Healthier Living and a Growing Hispanic Population
WEDNESDAY, Aug. 23, 2023 (American Heart Association News) — Patricia Guevara enjoys doing things with her 5-year-old daughter, Miranda, especially painting and drawing and taking an occasional walk in the park.After a promotora, or community health …
Learn MoreAHA News: A Lifetime of Challenges – Including a Spinal Stroke – Leads Dancer to Infinite Possibilities
WEDNESDAY, Aug. 23, 2023 (American Heart Association News) — As a Japanese American girl growing up in Irvine, California, Marisa Hamamoto felt like an outsider in her predominantly white community. Her schoolmates picked on her because she looked di…
Learn MoreHeterogeneity Found in Appropriate Use Criteria for Imaging of CAD
WEDNESDAY, Aug. 23, 2023 (HealthDay News) — U.S. Centers for Medicare & Medicaid Services (CMS)-qualified Appropriate Use Criteria (AUC) for imaging of coronary artery disease (CAD) are heterogeneous and discrepant, according to a study published onl…
Learn MoreEASD: Factors Linked to Lower-Limb Amputation ID’d in Diabetes
WEDNESDAY, Aug. 23, 2023 (HealthDay News) — For people with newly diagnosed diabetes, the risk for lower-limb amputation (LLA) is increased for those with older age, males, and divorced individuals, according to a study to be presented at the annual …
Learn MoreNivolumab + Ipilimumab Tops Ipilimumab Alone in Metastatic Melanoma
WEDNESDAY, Aug. 23, 2023 (HealthDay News) — For patients with metastatic melanoma who receive frontline anti-programmed death protein 1 (PD-1) or therapy against programmed cell death 1 ligand 1 and whose tumors progressed with cytotoxic T-lymphocyte…
Learn MoreImmune Checkpoint Inhibitors Can Be Active in Penile Cancer
WEDNESDAY, Aug. 23, 2023 (HealthDay News) — Immune checkpoint inhibitors (ICIs) are active in some patients with penile cancer (PeCa), according to a study published online Aug. 11 in the Journal of the National Cancer Institute.Talal El Zarif, M.D.,…
Learn MoreSacrospinous Hysteropexy Inferior to Manchester Procedure for Uterine Descent
WEDNESDAY, Aug. 23, 2023 (HealthDay News) — For patients with uterine descent, sacrospinous hysteropexy is inferior to the Manchester procedure for first surgical treatment, according to a study published in the Aug. 15 issue of the Journal of the Am…
Learn MoreScientists Decode the Y Chromosome, Key to Male Development
WEDNESDAY, Aug. 23, 2023 (HealthDay News) — An international research team has achieved the first complete sequencing of the human Y chromosome, which is closely linked to male development.This is the last of the human chromosomes to be fully sequenc…
Learn MoreALS Robbed Her of Speech, But Technology Is Changing That
WEDNESDAY, Aug. 23, 2023 (HealthDay News) — Many people with Lou Gehrig’s disease, also called amyotrophic lateral sclerosis (ALS), first start to lose the ability to move their arms and legs.That’s not Pat Bennett. She can move just fine. She can st…
Learn More